blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3161130

EP3161130 - STEM CELL SUBPOPULATIONS WITH DIFFERENTIAL GSTT1 EXPRESSION OR GENOTYPE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 14.11.2024
FormerThe patent has been granted
Status updated on  21.02.2020
FormerGrant of patent is intended
Status updated on  13.10.2019
FormerExamination is in progress
Status updated on  11.02.2019
FormerRequest for examination was made
Status updated on  23.11.2018
FormerThe application is deemed to be withdrawn
Status updated on  16.11.2018
FormerRequest for examination was made
Status updated on  31.03.2017
FormerThe international publication has been made
Status updated on  16.12.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Agency for Science, Technology and Research
1 Fusionopolis Way 20-10 Connexis
Singapore 138632 / SG
[2017/18]
Inventor(s)01 / STANTON, Lawrence
c/o Agency for Science
Technology and Research
60 Biopolis Street
02-01-Genome
Singapore 138672 / SG
02 / SATHIYANATHAN, Padmapriya
c/o Agency for Science
Technology and Research
60 Biopolis Street
02-01-Genome
Singapore 138672 / SG
03 / COOL, Simon
c/o Agency for Science
Technology and Research
8A Biomedical Grove
06-06 Immunos
Singapore 138648 / SG
04 / NURCOMBE, Victor
c/o Agency for Science
Technology and Research
8A Biomedical Grove
06-06 Immunos
Singapore 138648 / SG
05 / SAMSONRAJ, Rebekah M.
c/o Agency for Science
Technology and Research
8A Biomedical Grove
06-06 Immunos
Singapore 138648 / SG
 [2017/18]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2020/13]Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Former [2017/18]Clegg, Richard Ian, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date15811279.726.06.2015
[2017/18]
WO2015SG50184
Priority number, dateSG20141003640X26.06.2014         Original published format: SG10201403640X
[2017/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015199619
Date:30.12.2015
Language:EN
[2015/52]
Type: A1 Application with search report 
No.:EP3161130
Date:03.05.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.2015 takes the place of the publication of the European patent application.
[2017/18]
Type: B1 Patent specification 
No.:EP3161130
Date:25.03.2020
Language:EN
[2020/13]
Search report(s)International search report - published on:AU30.12.2015
(Supplementary) European search report - dispatched on:EP27.11.2017
ClassificationIPC:C12N5/074, C12N5/0735, C12N5/0775, A61K35/545, C12Q1/68, A61K35/28, A61P19/00
[2017/52]
CPC:
A61K35/545 (EP,US); A61K35/28 (US); A61P19/00 (EP);
A61P19/08 (EP); A61P43/00 (EP); C12N5/0662 (US);
C12N5/0663 (EP,US); C12Q1/6881 (EP,US); C12Y205/01018 (EP,US);
C12Q2600/158 (EP,US) (-)
Former IPC [2017/18]C12N5/074, C12N5/0735, C12N5/0775, A61K35/545, C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/18]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:STAMMZELLENSUBPOPULATIONEN MIT DIFFERENTIELLER GSTT1-EXPRESSION ODER GENOTYP[2017/18]
English:STEM CELL SUBPOPULATIONS WITH DIFFERENTIAL GSTT1 EXPRESSION OR GENOTYPE[2017/18]
French:SOUS-POPULATIONS DE CELLULES SOUCHES À GÉNOTYPE OU EXPRESSION DE GSTT1 DIFFÉRENCIÉS[2017/18]
Entry into regional phase29.12.2016National basic fee paid 
29.12.2016Search fee paid 
29.12.2016Designation fee(s) paid 
29.12.2016Examination fee paid 
Examination procedure16.12.2016Date on which the examining division has become responsible
29.12.2016Examination requested  [2017/18]
26.06.2018Application deemed to be withdrawn, date of legal effect  [2018/51]
deletedDeletion: Application deemed to be withdrawn, date of legal effect  [2018/52]
31.07.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2018/52]
03.08.2018Amendment by applicant (claims and/or description)
14.02.2019Despatch of a communication from the examining division (Time limit: M04)
13.06.2019Reply to a communication from the examining division
14.10.2019Communication of intention to grant the patent
12.02.2020Fee for grant paid
12.02.2020Fee for publishing/printing paid
12.02.2020Receipt of the translation of the claim(s)
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
03.08.2018Request for further processing filed
03.08.2018Full payment received (date of receipt of payment)
Request granted
15.08.2018Decision despatched
The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
03.08.2018Request for further processing filed
03.08.2018Full payment received (date of receipt of payment)
Request granted
15.08.2018Decision despatched
Fees paidRenewal fee
29.07.2017Renewal fee patent year 03
18.07.2018Renewal fee patent year 04
18.06.2019Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.06.201703   M06   Fee paid on   29.07.2017
30.06.201804   M06   Fee paid on   18.07.2018
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.06.2015
AL25.03.2020
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
MK25.03.2020
MT25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
TR25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IE26.06.2020
LU26.06.2020
BE30.06.2020
IS25.07.2020
PT18.08.2020
[2022/31]
Former [2022/30]HU26.06.2015
AL25.03.2020
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
MT25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
TR25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IE26.06.2020
LU26.06.2020
BE30.06.2020
IS25.07.2020
PT18.08.2020
Former [2022/27]HU26.06.2015
AT25.03.2020
CY25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
MT25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
TR25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IE26.06.2020
LU26.06.2020
BE30.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/24]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IE26.06.2020
LU26.06.2020
BE30.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/20]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IE26.06.2020
LU26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/15]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
LU26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/10]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/09]AT25.03.2020
CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/08]CZ25.03.2020
DK25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/50]CZ25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/49]CZ25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/48]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/47]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/46]FI25.03.2020
HR25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/45]FI25.03.2020
HR25.03.2020
LV25.03.2020
NL25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
Former [2020/39]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
Former [2020/38]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
GR26.06.2020
Former [2020/37]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
Former [2020/35]FI25.03.2020
NO25.06.2020
Documents cited:Search[Y]US2005019911  (GRONTHOS STAN [AU], et al) [Y] 1-9,12-15 * see claims and [044]-[045] *;
 [XY]US2006269925  (NUNES FABIO [US], et al) [X] 15 * see claims * [Y] 1-9,12-15;
 [Y]WO2012088225  (TULANE UNIVERSITY [US], et al) [Y] 1-9,12-15 * see claims and [050] *;
 [X]  - FUJIMOTO KAZUNORI ET AL, "Generation and functional characterization of mice with a disrupted Glutathione S-transferase, theta 1 gene", DRUG METABOLISM AND DISPOSITION, (200712), vol. 35, no. 12, pages 2196 - 2202, XP002775593 [X] 7-9 * see abstract and page 2197 *

DOI:   http://dx.doi.org/10.1124/dmd.107.017905
International search[X]WO2005005601  (UNIV MICHIGAN [US], et al) [X] 1-4, 8-15, 17, 24 * Abstract; Example 4; Table 4, page 30, line 3; Table 5, page 35, line 26; Table 7C, page 46, line 59; Table 7A, page 42, line 66; Table 7A, page 43, line 24; Table 7C, page 47, line 9; Table 7C, page 46, line 52; Table 5, page 35, line 70; Table 4, page 31, line 22; Table 5, page 37, line 51; Table *;
 [X]WO2007030693  (US GOV HEALTH & HUMAN SERV [US], et al) [X] 9-18 * Claims, entire document *;
 [X]WO2012141971  (UNIV LELAND STANFORD JUNIOR [US], et al) [X] 9-18 * Claims, entire document *;
 [X]  - WU, H. et al., "Copy number variant analysis of human embryonic stem cells", Stem Cells, (20080000), vol. 26, no. 6, ISSN 1066-5099, pages 1484 - 1489, XP055248340 [X] 1-25 * Supplementary Table 2; Figure 1, page 1488, left hand column, para 3, lines 5-6; Discussion *

DOI:   http://dx.doi.org/10.1634/stemcells.2007-0993
 [X]  - SHAO, J. et al., "Cytochrome P450 and glutathione S-transferase mRNA expression in human fetal liver hematopoietic stem cells", Drug Metabolism and Disposition, (20070000), vol. 35, no. 1, ISSN 0090-9556, pages 168 - 175, XP055248341 [X] 1-5, 14-15, 17 * Abstract *

DOI:   http://dx.doi.org/10.1124/dmd.106.012757
 [X]  - LUSTREMANT, C. et al., "Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis", Cellular Reprogramming, (20130000), vol. 15, pages 233 - 246, XP055248345 [X] 1-4, 14-15, 17 * Abstract; Table 2 *

DOI:   http://dx.doi.org/10.1089/cell.2012.0076
 [X]  - OKADA, R. et al., "Direct and rapid genotyping of glutathione-s-transferase M1 and T1 from human blood specimens using the SmartAmp2 method", Drug Metabolism and Disposition, (20100000), vol. 38, no. 10, ISSN 0090-9556, pages 1636 - 1639, XP055248349 [X] 25 * Abstract; Materials and Methods *

DOI:   http://dx.doi.org/10.1124/dmd.110.034652
 [A]  - AGUILERA, I. et al., "Clinical relevance of GSTT1 mismatch in solid organ and hematopoietic stem cell transplantation", Human Immunology, (20130000), vol. 74, no. 11, ISSN 0198-8859, pages 1470 - 1473, XP055248347 [A] 0 * Entire document *

DOI:   http://dx.doi.org/10.1016/j.humimm.2013.06.004
 [A]  - LORDELO, G. S. et al., "Association between methylene tetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population", Genetics and Molecular Research, (20120000), vol. 11, no. 2, pages 1013 - 1026, XP055248346 [A] 0 * Entire document *

DOI:   http://dx.doi.org/10.4238/2012.April.19.6
by applicantUS2005019911
 WO2012088225
    - GANG et al., Blood, (20070000), vol. 109, pages 1743 - 1751
    - BATTULA et al., Haematologica-the Hematology Journal, (20090000), vol. 94, pages 173 - 184
    - TORMIN et al., Blood, (20110000), vol. 117, pages 5067 - 5077
    - COLTER et al., Proceedings of the National Academy of Sciences of the United States of America, (20010000), vol. 98, pages 7841 - 7845
    - SMITH et al., Stem Cells, (20040000), vol. 22, pages 823 - 831
    - CAPLANDENNIS, Journal of Cellular Biochemistry, (20060000), vol. 98, pages 1076 - 1084
    - CAPLANCORREA, Cell Stem Cell, (20110000), vol. 9, pages 11 - 15
    - CAPLAN, Journal of Pathology, (20090000), vol. 217, pages 318 - 324
    - FUJIMOTO et al., Drug Metabolism & Diposition, (20070000), vol. 35, no. 12, pages 2196 - 2202
    - TAKAHASHI, K.YAMANAKA, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors", Cell, (20060000), vol. 126, pages 663 - 676
    - YAMANAKA S et al., Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
    - YAMANAKA S, "Generation of germline-competent induced pluripotent stem cells", Nature, (20070000), vol. 448, doi:doi:10.1038/nature05934, pages 313 - 7, XP002555950

DOI:   http://dx.doi.org/10.1038/nature05934
    - WERNIG M, "In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state", Nature, (20070000), vol. 448, doi:doi:10.1038/NATURE05944, pages 318 - 24, XP002621304

DOI:   http://dx.doi.org/10.1038/NATURE05944
    - MAHERALI N, "Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution", Cell Stem Cell, (20070000), vol. 1, doi:doi:10.1016/j.stem.2007.05.014, pages 55 - 70, XP009091847

DOI:   http://dx.doi.org/10.1016/j.stem.2007.05.014
    - THOMSON JAYU J et al., "Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells", Science
    - TAKAHASHI et al., "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", Cell, (20070000), vol. 131, no. 5, doi:doi:10.1016/j.cell.2007.11.019, pages 861 - 72, XP055547222

DOI:   http://dx.doi.org/10.1016/j.cell.2007.11.019
    - MATSUI et al., "Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture", Cell, (19920000), vol. 70, doi:doi:10.1016/0092-8674(92)90317-6, pages 841 - 847, XP024245512

DOI:   http://dx.doi.org/10.1016/0092-8674(92)90317-6
    - JIANG et al., "Pluripotency of mesenchymal stem cells derived from adult marrow", Nature, (20020000), vol. 418, doi:doi:10.1038/nature00870, pages 41 - 49, XP002559664

DOI:   http://dx.doi.org/10.1038/nature00870
    - KANATSU-SHINOHARA et al., "Generation of pluripotent stem cells from neonatal mouse testis", Cell, (20040000), vol. 119, doi:doi:10.1016/j.cell.2004.11.011, pages 1001 - 1012, XP002985005

DOI:   http://dx.doi.org/10.1016/j.cell.2004.11.011
    - KLIMANSKAYA ICHUNG YBECKER SLU SJLANZA R, "Human embryonic stem cell lines derived from single blastomeres", Nature, (20060000), vol. 444, doi:doi:10.1038/nature05142, pages 481 - 485, XP009076989

DOI:   http://dx.doi.org/10.1038/nature05142
    - LEI et al., "Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges", Cell Research, (20070000), vol. 17, pages 682 - 688
    - CHUNG YKLIMANSKAYA IBECKER S et al., "Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres", Nature, (20060000), vol. 439, doi:doi:10.1038/nature04277, pages 216 - 219, XP007901044

DOI:   http://dx.doi.org/10.1038/nature04277
    - CHUNG YKLIMANSKAYA IBECKER S et al., "Human embryonic stem cell lines generated without embryo destruction", Cell Stem Cell, (20080000), vol. 2, pages 113 - 117
    - DUSKO ILIC et al., "Derivation of human embryonic stem cell lines from biopsied blastomeres on human feeders with a minimal exposure to xenomaterials", Stem Cells And Development - paper in pre-publication
    - ZHANG XSTOJKOVIC PPRZYBORSKI S et al., "Derivation of human embryonic stem cells from developing and arrested embryos", Stem Cells, (20060000), vol. 24, doi:doi:10.1634/stemcells.2006-0377, pages 2669 - 2676, XP002471258

DOI:   http://dx.doi.org/10.1634/stemcells.2006-0377
    - LIN et al., "Multilineage potential of homozygous stem cells derived from metaphase II oocytes", Stem Cells., (20030000), vol. 21, no. 2, doi:doi:10.1634/stemcells.21-2-152, pages 152 - 61, XP002243096

DOI:   http://dx.doi.org/10.1634/stemcells.21-2-152
    - CHRIS H. JO et al., "Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion", Cell Tissue Res, (20080000), vol. 334, pages 423 - 433, XP019716547
    - WINSTON COSTA PEREIRA et al., "Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation", J Tissue Eng Regen Med, (20080000), vol. 2, pages 394 - 399
    - TROYERWEISS, "Concise Review: Wharton's Jelly-Derived Cells Are a primitive Stromal Cell Population", Stem Cells, (20080000), vol. 26, doi:doi:10.1634/stemcells.2007-0439, pages 591 - 599, XP055059242

DOI:   http://dx.doi.org/10.1634/stemcells.2007-0439
    - KIM et al., "Ex vivo characteristics of human amniotic membrane-derived stem cells", Cloning Stem Cells, (20070000), vol. 9, no. 4, doi:doi:10.1089/clo.2007.0027, pages 581 - 94, XP002465150

DOI:   http://dx.doi.org/10.1089/clo.2007.0027
    - CHUNG et al., "Human Embryonic Stem Cell Lines Generated without Embryo Destruction", Cell Stem Cell, (20080000), vol. 2, no. 2, pages 113 - 117
    - BUCHARD et al., J Mol Diagn, (20070000), vol. 9, no. 5, pages 612 - 617
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.